MICAELA SIMON: Open Payments
NPI 1235681370 · TEMPE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$16,431 in 114 payments from 20 companies in 2025. Trend: 2023 $3,149 · 2024 $12,320 · 2025 $16,431
Speaker / faculty: $10,928Food & beverage: $3,122Travel & lodging: $2,381
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 42 | $9,197 |
| ViiV Healthcare Company | 45 | $6,659 |
| Merck Sharp & Dohme LLC | 5 | $145 |
| EMD Serono, Inc. | 2 | $49 |
| Amgen Inc. | 3 | $47 |
| ABBVIE INC. | 2 | $47 |
| Novo Nordisk Inc | 2 | $29 |
| Indivior Inc. | 1 | $28 |
| PFIZER INC. | 1 | $27 |
| Medtronic, Inc. | 1 | $26 |
Products named: Descovy, APRETUDE, Yeztugo, DOVATO, PIFELTRO, RUKOBIA, CABENUVA, Biktarvy.
Industry payments across AZ — which companies pay providers there.
